Intravenous hematin shows promise for treating acute porphyria attacks. This therapy effectively reduced key urinary markers and improved patient symptoms, offering a new treatment option for acute hepatic porphyria (AIP) and variegate porphyria (VP).
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: